National and Kapodistrian University of Athens
Η μέθοδος της αναστολής Rast στην ταυτοποίηση του υπεύθυνου για την κλινική συμπτωματολογία αλλεργιογόνου σε άτομα με in vitro IgE τύπου διασταυρούμενη αντίδραση σε διάφορα αλλεργιογόνα
Abstract
dc:descriptionThe evaluation of the diagnostic value of the method of inhibiting CAP FEIA to investigate cross-reactions between bee and wasp Hymenoptera, with the newly emerging method of recombinant allergens (component resolved diagnosis). Benefit: Many important knowledge to solve clinical dilemmas regarding the initiation of specific immunotherapy. Frommeasurements with inhibition CAP FEIA shows that 18% of patients were doubly sensitized with full cross-reactivity to a venom.Important is the percentage of the partial cross-reaction 33.3%.47.3% of sIgE to CCDs in our patients, double than single awareness, indicates the important role of these cross-reactions in children with double positivity.44% of double-positive patients on recombinant allergens, confirms the assessment of sIgE to recombinant allergens of both poisons as a remarkable approach to distinguish true double sensitization and cross-reactivity in patients with double positivity in BV & VV.The specificity and sensitivity of the sIgE of recombinant allergens are exceptional. These measurements can help a lot faster and cheaper than the FEIA inhibition, in distinguishing the true double sensitization to cross-reaction.The sensitization of phospholipase A2 (Api m 1), 75% in patients with single sensitivity confirms that phospholipase A2 (Api m 1) is the major allergen of bee.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Παλαιολόγου, Νικολέττα
- Palaiologou, Nikoleta
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29537